ConclusionIn patients who need urgent surgery after recently diagnosed STEMI and implanted DES, a strategy using tirofiban may allow temporary withdrawal of dual antiplatelet drugs without increasing the risk of bleeding. This conclusion needs to be further confirmed by large-scale randomized clinical trials. (Source: Coronary Artery Disease)
Source: http://www.medworm.com/index.php?rid=7459630&cid=u_0_7_f&fid=34135&url=http%3A%2F%2Fjournals.lww.com%2Fcoronary-artery%2FFulltext%2F2013%2F09000%2FShort_term_follow_up_of_tirofiban_as_alternative.11.aspx
phlebotomy certification chicago phlebotomy training bay area free phlebotomy training
No comments:
Post a Comment